OPTIC PATHWAY GLIOMA

Clinical trials for OPTIC PATHWAY GLIOMA explained in plain language.

Never miss a new study

Get alerted when new OPTIC PATHWAY GLIOMA trials appear

Sign up with your email to follow new studies for OPTIC PATHWAY GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 3 Completed 1

New hope for kids with resistant tumors? early trial tests CUDC-907

Disease control Completed

This early-phase study tested a new drug called CUDC-907 in 26 children and young adults (ages 1-21) with cancers that had come back or stopped responding to treatment, including solid tumors, brain tumors, and lymphoma. The main goal was to find a safe dose and check for side ef…

Matched conditions: OPTIC PATHWAY GLIOMA

Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Jun 27, 2026 09:04 UTC

OPTIC PATHWAY GLIOMA

Get alerted when new OPTIC PATHWAY GLIOMA trials appear

New hope for kids with resistant tumors? early trial tests CUDC-907